A novel molecule 'shati' increases dopamine uptake via the induction of tumor necrosis factor-α in pheochromocytoma-12 cells

Journal of Neurochemistry

Volumn 107, Issue 6, 2008, Pages 1697-1708

  Niwa, Minae ^a,b   Nitta, Atsumi ^a   Cen, Xiaobo ^a   Kitaichi, Kiyoyuki ^c   Ozaki, Norio ^a   Yamada, Kiyofumi ^a   Nabeshima, Toshitaka ^a,b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

^c NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

Addiction; Dopamine (DA) uptake; Methamphetamine; Shati; Tumor necrosis factor (TNF )

Indexed keywords

COMPLEMENTARY DNA; DOPAMINE; MESSENGER RNA; METHAMPHETAMINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN DERIVATIVE; PROTEIN SHATI; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CELL LINE; CONTROLLED STUDY; DOPAMINE UPTAKE; DRUG DEPENDENCE; GENETIC TRANSFECTION; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ACETYLTRANSFERASES; ANALYSIS OF VARIANCE; ANIMALS; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; MALE; METHAMPHETAMINE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PC12 CELLS; RATS; TRANSFECTION; TRITIUM; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE 3-MONOOXYGENASE;

MUS;

EID: 56749175369     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05738.x     Document Type: Article

References (47)

1. Amara S. G. Kuhar M. J. (1993) Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci. 16, 73 93.
2. Barone F. C., Arvin B., White R. F., Miller A., Webb C. L., Willette R. N., Lysko P. G. Feuerstein G. Z. (1997) TNF-α. A mediator of focal ischemic brain injury. Storoke 28, 1233 1244.
3. Baud V. Karin K. (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11, 372 377. Review.
4. Boka G., Anglade P., Wallach D., Javoy-Agid F., Agid Y. Hirsch E. C. (1994) Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett. 172, 151 154.
5. Cen X., Nitta A., Ibi D., Zhao Y., Niwa M., Taguchi K., Hamada M., Ito Y., Ito Y., Wang L. Nabeshima T. (2008) Identification of piccolo as a regulator of behavioral plasticity and dopamine transporter internalization. Mol. Psychiatr. 13, 451 463.
6. Chen N. H., Reith M. E. Quick M. W. (2004) Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflugers Arch. 447, 519 531. Review.
7. Devin A., Lin Y. Liu Z. G. (2003) The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases. EMBO 4, 623 627.
8. Finberg J. P. Youdim M. B. (1983) Selective MAO A and B inhibitors: their mechanism of action and pharmacology. Neuropharmacology 22, 441 446. Review.
9. Fog J. U., Khoshbouei H., Holy M. et al. (2006) Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51, 417 429.
10. Fornai F., Lenzi P., Lazzeri G., Ferrucci M., Fulceri F., Giorgi F. S., Falleni A., Ruggieri S. Paparelli A. (2007) Fine ultrastructure and biochemistry of PC12 cells: a comparative approach to understand neurotoxicity. Brain Res. 1129, 174 190.
11. Franklin K. B. J. Paxinos G. (1997) The Mouse Brain: In Stereotaxic Coordinates. Academic Press, San Diego.
12. Grace A. A. (1995) The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function. Drug Alcohol Depend. 37, 111 129. Review.
13. Greene L. A. Rein G. (1978) Short-term regulation of catecholamine biosynthesis in a nerve growth factor responsive clonal line of rat pheochromocytoma cells. J. Neurochem. 30, 549 555.
14. Guha M., Bai W., Nadler J. L. Natarajan R. (2000) Molecular mechanisms of tumor necrosis factor α gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J. Biol. Chem. 275, 17728 17739.
15. Horn A. S. (1990) Dopamine uptake: a review of progress in the last decade. Prog. Neurobiol. 34, 387 400. review.
16. Hsu H., Xiong J. Goeddel D. V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81, 495 504.
17. Hyman S. E. (1996) Addiction to cocaine and amphetamine. Neuron 16, 901 904.
18. Jones S. R., Gainetdinov R. R., Jaber M., Giros B., Wightman R. M. Caron M. G. (1998) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl Acad. Sci. USA 95, 4029 4034.
19. Koob G. F. (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13, 177 184.
20. Koob G. F., Sanna P. P. Bloom F. E. (1998) Neuroscience of addiction. Neuron 21, 467 476.
21. Loder M. K. Melikian H. E. (2003) The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J. Biol. Chem. 278, 22168 22174.
22. Maier S. F. Watkins L. R. (1998) Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol. Rev. 105, 83 107.
23. Markey K. A., Kondo H., Shenkman L. Goldstein M. (1980) Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line. Mol. Pharmacol. 17, 79 85.
24. Melikian H. E. Buckley K. M. (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 19, 7699 7710.
25. Morón J. A., Zakharova I., Ferrer J. V. et al. (2003) Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J. Neurosci. 23, 8480 8488.
26. Nakajima A., Yamada K., Nagai T. et al. (2004) Role of tumor necrosis factor-α in methamphetamine-induced drug dependence and neurotoxicity. J. Neurosci. 24, 2212 2225.
27. Nestler E. J. (2001) Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2, 119 128.
28. Niwa M., Nitta A., Mizoguchi H., Ito Y., Noda Y., Nagai T. Nabeshima T. (2007a) A novel molecule 'shati' is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference. J. Neurosci. 27, 7604 7615.
29. Niwa M., Nitta A., Shen L., Noda Y. Nabeshima T. (2007b) Involvement of glial cell line-derived neurotrophic factor in inhibitory effects of a hydrophobic dipeptide Leu-Ile on morphine-induced sensitization and rewarding effects. Behav. Brain Res. 179, 167 171.
30. Niwa M., Nitta A., Yamada K. Nabeshima T. (2007c) The roles of glial cell line-derived neurotrophic factor, tumor necrosis factor-α, and an inducer of these factors in drug dependence. J. Pharmacol. Sci. 104, 116 121.
31. Niwa M., Nitta A., Yamada Y., Nakajima A., Saito K., Seishima M., Noda Y. Nabeshima T. (2007d) Tumor necrosis factor-α and its inducer inhibit morphine-induced rewarding effects and sensitization. Biol. Psychiatry 62, 658 668.
32. Niwa M., Nitta A., Yamada Y., Nakajima A., Saito K., Seishima M., Shen L., Noda Y., Furukawa S. Nabeshima T. (2007e) An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-α protects against methamphetamine-induced rewarding effects and sensitization. Biol. Psychiatry 61, 890 901.
33. Niwa M., Yan Y. Nabeshima T. (2008) Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction. Ann. NY Acad. Sci. 1141, 76 95.
34. Rahman I. MacNee W. (2000) Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic. Biol. Med. 28, 1405 1420.
35. Rawson R. A., Gonzales R. Brethen P. (2002) Treatment of methamphetamine use disorders: an update. J. Subst. Abuse Treat. 23, 145 150. Review.
36. Roda L. G., Nolan J. A., Kim S. U. Hogue-Angeletti R. A. (1980) Isolation and characterization of chromaffin granules from a pheochromocytoma (PC 12) cell line. Exp. Cell Res. 128, 103 109.
37. Sampath D., Jackson G. R., Werrbach-Perez K. Perez-Polo J. R. (1994) Effects of nerve growth factor on glutathione peroxidase and catalase in PC12 cells. J. Neurochem. 62, 2476 2479.
38. Self D. W. Nestler E. J. (1995) Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18, 463 495. Review.
39. Sulzer D., Sonders M. S., Poulsen N. W. Galli A. (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406 433.
40. Tischler A. S. (2002) Chromaffin cells as models of endocrine cells and neurons. Ann. NY Acad. Sci. 971, 366 370. Review.
41. Torres G. E., Gainetdinov R. R. Caron M. G. (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci. 4, 13 25. Review.
42. Vaccaro K. K., Liang B. T., Perelle B. A. Perlman R. L. (1980) Tyrosine 3-monooxygenase regulates catecholamine synthesis in pheochromocytoma cells. J. Biol. Chem. 255, 6539 6541.
43. Vassalli P. (1992) The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10, 411 452. Review.
44. van Vliet C., Bukczynska P. E., Puryer M. A., Sadek C. M., Shields B. J., Tremblay M. L. Tiganis T. (2005) Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase. Nat. Immunol. 6, 253 260.
45. Wada R., Tifft C. J. Proia R. L. (2000) Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc. Natl Acad. Sci. USA 97, 10954 10959.
46. Wise R. A. (1996) Neurobiology of addiction. Curr. Opin. Neurobiol. 6, 243 251.
47. Youdim M. B. (1991) PC12 cells as a window for the differentiation of neural crest into adrenergic nerve ending and adrenal medulla. J. Neural Transm. Suppl. 34, 61 67.